Systemic effects of ADP-induced platelet aggregation and their modification by aspirin and by pyridinolcarbamate.
D000244:Adenosine Diphosphate / Q000494:pharmacology*; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001241:Aspirin / Q000494:pharmacology*; D001772:Blood Cell Count; D001792:Blood Platelets; D001919:Bradycardia / Q000139:chemically induced; D002219:Carbamates / Q000494:pharmacology*; D002339:Carotid Arteries; D002496:Central Venous Pressure / Q000187:drug effects; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D007022:Hypotension / Q000139:chemically induced; D008833:Microcirculation; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011727:Pyridinolcarbamate / Q000494:pharmacology; D051381:Rats
D002219:Carbamates; D000960:Hypolipidemic Agents; D000244:Adenosine Diphosphate; D011727:Pyridinolcarbamate; D001241:Aspirin; D010100:Oxygen